English
简体中文
Total: £ 56.28
Published Date: 2025-06-23 | Pages: 146 | Tables: 152 | Pharma & Healthcare
In 2024, the global market size of Respiratory Drug was estimated to be worth US$ 48140 million and is forecast to reach approximately US$ 71040 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.
Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.
North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.
Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Respiratory Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Drug.
The Respiratory Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
Segment by Type
Inhalable & Nasal Spray
Oral
Others
Segment by Application
Hospital
Drugs Store
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Respiratory Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Respiratory Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Respiratory Drug Product Introduction
1.2 Market by Type
1.2.1 Global Respiratory Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Respiratory Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Respiratory Drug Market Size Estimates and Forecasts
2.1.1 Global Respiratory Drug Revenue 2020-2031
2.1.2 Global Respiratory Drug Sales 2020-2031
2.2 Respiratory Drug Market Size by Region: 2024 Versus 2031
2.3 Respiratory Drug Sales by Region (2020-2031)
2.3.1 Global Respiratory Drug Sales by Region: 2020-2025
2.3.2 Global Respiratory Drug Sales Forecast by Region (2026-2031)
2.3.3 Global Respiratory Drug Sales Market Share by Region (2020-2031)
2.4 Respiratory Drug Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Respiratory Drug Revenue by Region: 2020-2025
2.4.2 Global Respiratory Drug Revenue Forecast by Region (2026-2031)
2.4.3 Global Respiratory Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Respiratory Drug Sales by Type (2020-2031)
3.1.1.1 Global Respiratory Drug Sales Volume by Type (2020-2031)
3.1.1.2 Global Respiratory Drug Sales Market Share by Type (2020-2031)
3.1.2 Global Respiratory Drug Revenue by Type (2020-2031)
3.1.2.1 Global Respiratory Drug Revenue by Type (2020-2031)
3.1.2.2 Global Respiratory Drug Revenue Market Share by Type (2020-2031)
3.1.3 Respiratory Drug Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Respiratory Drug Sales by Application (2020-2031)
3.2.1.1 Global Respiratory Drug Sales Volume by Application (2020-2031)
3.2.1.2 Global Respiratory Drug Sales Market Share by Application (2020-2031)
3.2.2 Global Respiratory Drug Revenue by Application (2020-2031)
3.2.2.1 Global Respiratory Drug Revenue by Application (2020-2031)
3.2.2.2 Global Respiratory Drug Revenue Market Share by Application (2020-2031)
3.2.3 Respiratory Drug Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Inhalable & Nasal Spray of Respiratory Drug Revenue Market Share by Application
3.3.2 Oral of Respiratory Drug Revenue Market Share by Application
3.3.3 Others of Respiratory Drug Revenue Market Share by Application
4 Global Respiratory Drug by Manufacturers
4.1 Global Top Respiratory Drug Manufacturers by Sales (2020-2025)
4.1.1 Global Respiratory Drug Sales by Manufacturer (2020-2025)
4.1.2 Global Respiratory Drug Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Respiratory Drug Manufacturers by Revenue (2020-2025)
4.2.1 Global Respiratory Drug Revenue by Manufacturer (2020-2025)
4.2.2 Global Respiratory Drug Revenue Share by Manufacturer (2020-2025)
4.3 Global Respiratory Drug Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Respiratory Drug Manufacturers Covered: Ranking by Revenue
4.4.2 Global Respiratory Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Respiratory Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Respiratory Drug Manufacturing Base Distribution, Product Type
4.5.1 Respiratory Drug Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Respiratory Drug Market
4.5.3 Manufacturers Respiratory Drug Product Type and Application
4.5.4 Inhalable & Nasal Spray Market Sales of Respiratory Drug by Manufacturer
4.5.5 Oral Market Sales of Respiratory Drug by Manufacturer
4.5.6 Others Market Sales of Respiratory Drug by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 GSK
5.1.1 GSK Company Information
5.1.2 GSK Description, Business Overview
5.1.3 GSK Respiratory Drug Products Offered
5.1.4 GSK Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.1.5 GSK Respiratory Drug Sales by Product in 2024
5.1.6 GSK Respiratory Drug Sales by Application in 2024
5.1.7 GSK Respiratory Drug Sales by Geographic Area in 2024
5.1.8 GSK Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Company Information
5.2.2 AstraZeneca Description, Business Overview
5.2.3 AstraZeneca Respiratory Drug Products Offered
5.2.4 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.2.5 AstraZeneca Respiratory Drug Sales by Product in 2024
5.2.6 AstraZeneca Respiratory Drug Sales by Application in 2024
5.2.7 AstraZeneca Respiratory Drug Sales by Geographic Area in 2024
5.2.8 AstraZeneca Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Company Information
5.3.2 Boehringer Ingelheim Description, Business Overview
5.3.3 Boehringer Ingelheim Respiratory Drug Products Offered
5.3.4 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Boehringer Ingelheim Respiratory Drug Sales by Product in 2024
5.3.6 Boehringer Ingelheim Respiratory Drug Sales by Application in 2024
5.3.7 Boehringer Ingelheim Respiratory Drug Sales by Geographic Area in 2024
5.3.8 Boehringer Ingelheim Recent Developments
5.4 Vertex
5.4.1 Vertex Company Information
5.4.2 Vertex Description, Business Overview
5.4.3 Vertex Respiratory Drug Products Offered
5.4.4 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Vertex Respiratory Drug Sales by Product in 2024
5.4.6 Vertex Respiratory Drug Sales by Application in 2024
5.4.7 Vertex Respiratory Drug Sales by Geographic Area in 2024
5.4.8 Vertex Recent Developments
5.5 Roche
5.5.1 Roche Company Information
5.5.2 Roche Description, Business Overview
5.5.3 Roche Respiratory Drug Products Offered
5.5.4 Roche Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Roche Respiratory Drug Sales by Product in 2024
5.5.6 Roche Respiratory Drug Sales by Application in 2024
5.5.7 Roche Respiratory Drug Sales by Geographic Area in 2024
5.5.8 Roche Recent Developments
5.6 Novartis
5.6.1 Novartis Company Information
5.6.2 Novartis Description, Business Overview
5.6.3 Novartis Respiratory Drug Products Offered
5.6.4 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Novartis Respiratory Drug Sales by Product in 2024
5.6.6 Novartis Respiratory Drug Sales by Application in 2024
5.6.7 Novartis Respiratory Drug Sales by Geographic Area in 2024
5.6.8 Novartis Recent Developments
5.7 Teva
5.7.1 Teva Company Information
5.7.2 Teva Description, Business Overview
5.7.3 Teva Respiratory Drug Products Offered
5.7.4 Teva Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Teva Respiratory Drug Sales by Product in 2024
5.7.6 Teva Respiratory Drug Sales by Application in 2024
5.7.7 Teva Respiratory Drug Sales by Geographic Area in 2024
5.7.8 Teva Recent Developments
5.8 Chiesi
5.8.1 Chiesi Company Information
5.8.2 Chiesi Description, Business Overview
5.8.3 Chiesi Respiratory Drug Products Offered
5.8.4 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Chiesi Respiratory Drug Sales by Product in 2024
5.8.6 Chiesi Respiratory Drug Sales by Application in 2024
5.8.7 Chiesi Respiratory Drug Sales by Geographic Area in 2024
5.8.8 Chiesi Recent Developments
5.9 Mylan
5.9.1 Mylan Company Information
5.9.2 Mylan Description, Business Overview
5.9.3 Mylan Respiratory Drug Products Offered
5.9.4 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Mylan Respiratory Drug Sales by Product in 2024
5.9.6 Mylan Respiratory Drug Sales by Application in 2024
5.9.7 Mylan Respiratory Drug Sales by Geographic Area in 2024
5.9.8 Mylan Recent Developments
5.10 Sumitomo Dainippon
5.10.1 Sumitomo Dainippon Company Information
5.10.2 Sumitomo Dainippon Description, Business Overview
5.10.3 Sumitomo Dainippon Respiratory Drug Products Offered
5.10.4 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Sumitomo Dainippon Respiratory Drug Sales by Product in 2024
5.10.6 Sumitomo Dainippon Respiratory Drug Sales by Application in 2024
5.10.7 Sumitomo Dainippon Respiratory Drug Sales by Geographic Area in 2024
5.10.8 Sumitomo Dainippon Recent Developments
5.11 Merck
5.11.1 Merck Company Information
5.11.2 Merck Description, Business Overview
5.11.3 Merck Respiratory Drug Products Offered
5.11.4 Merck Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Merck Respiratory Drug Sales by Product in 2024
5.11.6 Merck Respiratory Drug Sales by Application in 2024
5.11.7 Merck Respiratory Drug Sales by Geographic Area in 2024
5.11.8 Merck Recent Developments
5.12 Beximco
5.12.1 Beximco Company Information
5.12.2 Beximco Description, Business Overview
5.12.3 Beximco Respiratory Drug Products Offered
5.12.4 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Beximco Respiratory Drug Sales by Product in 2024
5.12.6 Beximco Respiratory Drug Sales by Application in 2024
5.12.7 Beximco Respiratory Drug Sales by Geographic Area in 2024
5.12.8 Beximco Recent Developments
6 North America
6.1 North America Respiratory Drug Market Size YoY Growth 2020-2031
6.2 North America Respiratory Drug Market Facts & Figures by Country
6.2.1 North America Respiratory Drug Sales by Country (2020-2031)
6.2.2 North America Respiratory Drug Revenue by Country (2020-2031)
6.3 North America Respiratory Drug Sales by Type (2020-2025)
6.4 North America Respiratory Drug Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Respiratory Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Respiratory Drug Market Facts & Figures by Region
7.2.1 Asia-Pacific Respiratory Drug Sales by Region (2020-2031)
7.2.2 Asia-Pacific Respiratory Drug Revenue by Region (2020-2031)
7.3 Asia-Pacific Respiratory Drug Sales by Type (2020-2025)
7.4 Asia-Pacific Respiratory Drug Sales by Application (2020-2025)
8 Europe
8.1 Europe Respiratory Drug Market Size YoY Growth 2020-2031
8.2 Europe Respiratory Drug Market Facts & Figures by Country
8.2.1 Europe Respiratory Drug Sales by Country (2020-2031)
8.2.2 Europe Respiratory Drug Revenue by Country (2020-2031)
8.3 Europe Respiratory Drug Sales by Type (2020-2025)
8.4 Europe Respiratory Drug Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Respiratory Drug Market Size YoY Growth 2020-2031
9.2 Latin America Respiratory Drug Market Facts & Figures by Country
9.2.1 Latin America Respiratory Drug Sales by Country (2020-2031)
9.2.2 Latin America Respiratory Drug Revenue by Country (2020-2031)
9.3 Latin America Respiratory Drug Sales by Type (2020-2025)
9.4 Latin America Respiratory Drug Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Respiratory Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Respiratory Drug Market Facts & Figures by Country
10.2.1 Middle East and Africa Respiratory Drug Sales by Country (2020-2031)
10.2.2 Middle East and Africa Respiratory Drug Revenue by Country (2020-2031)
10.3 Middle East and Africa Respiratory Drug Sales by Type (2020-2025)
10.4 Middle East and Africa Respiratory Drug Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Respiratory Drug Supply Chain Analysis
11.2 Respiratory Drug Key Raw Materials and Upstream Suppliers
11.3 Respiratory Drug Clients Analysis
11.4 Respiratory Drug Sales Channel and Sales Model Analysis
11.4.1 Respiratory Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Respiratory Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Respiratory Drug Distributors
12 Respiratory Drug Market Dynamics
12.1 Respiratory Drug Industry Trends
12.2 Respiratory Drug Market Drivers
12.3 Respiratory Drug Market Challenges
12.4 Respiratory Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Respiratory Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Respiratory Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Respiratory Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Respiratory Drug Sales by Region (2020-2025) & (M Units)
Table 5. Global Respiratory Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Respiratory Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Respiratory Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Respiratory Drug Sales Volume by Type (2020-2025) & (M Units)
Table 9. Global Respiratory Drug Sales Volume by Type (2026-2031) & (M Units)
Table 10. Global Respiratory Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Respiratory Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Respiratory Drug Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Respiratory Drug Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Respiratory Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Respiratory Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Respiratory Drug Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Respiratory Drug Sales Share by Manufacturer (2020-2025)
Table 18. Respiratory Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Respiratory Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Respiratory Drug Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Respiratory Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Respiratory Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Respiratory Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drug as of 2024)
Table 24. Respiratory Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Respiratory Drug Market
Table 26. Manufacturers Respiratory Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. GSK Company Information
Table 29. GSK Description and Business Overview
Table 30. GSK Respiratory Drug Product
Table 31. GSK Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. GSK Sales Proportion of Respiratory Drug by Product in 2024
Table 33. GSK Sales Proportion of Respiratory Drug by Application in 2024
Table 34. GSK Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 35. GSK Recent Developments
Table 36. AstraZeneca Company Information
Table 37. AstraZeneca Description and Business Overview
Table 38. AstraZeneca Respiratory Drug Product
Table 39. AstraZeneca Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. AstraZeneca Sales Proportion of Respiratory Drug by Product in 2024
Table 41. AstraZeneca Sales Proportion of Respiratory Drug by Application in 2024
Table 42. AstraZeneca Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 43. AstraZeneca Recent Developments
Table 44. Boehringer Ingelheim Company Information
Table 45. Boehringer Ingelheim Description and Business Overview
Table 46. Boehringer Ingelheim Respiratory Drug Product
Table 47. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Boehringer Ingelheim Sales Proportion of Respiratory Drug by Product in 2024
Table 49. Boehringer Ingelheim Sales Proportion of Respiratory Drug by Application in 2024
Table 50. Boehringer Ingelheim Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 51. Boehringer Ingelheim Recent Developments
Table 52. Vertex Company Information
Table 53. Vertex Description and Business Overview
Table 54. Vertex Respiratory Drug Product
Table 55. Vertex Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Vertex Sales Proportion of Respiratory Drug by Product in 2024
Table 57. Vertex Sales Proportion of Respiratory Drug by Application in 2024
Table 58. Vertex Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 59. Vertex Recent Developments
Table 60. Roche Company Information
Table 61. Roche Description and Business Overview
Table 62. Roche Respiratory Drug Product
Table 63. Roche Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Roche Sales Proportion of Respiratory Drug by Product in 2024
Table 65. Roche Sales Proportion of Respiratory Drug by Application in 2024
Table 66. Roche Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 67. Roche Recent Developments
Table 68. Novartis Company Information
Table 69. Novartis Description and Business Overview
Table 70. Novartis Respiratory Drug Product
Table 71. Novartis Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Novartis Sales Proportion of Respiratory Drug by Product in 2024
Table 73. Novartis Sales Proportion of Respiratory Drug by Application in 2024
Table 74. Novartis Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 75. Novartis Recent Developments
Table 76. Teva Company Information
Table 77. Teva Description and Business Overview
Table 78. Teva Respiratory Drug Product
Table 79. Teva Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Teva Sales Proportion of Respiratory Drug by Product in 2024
Table 81. Teva Sales Proportion of Respiratory Drug by Application in 2024
Table 82. Teva Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 83. Teva Recent Developments
Table 84. Chiesi Company Information
Table 85. Chiesi Description and Business Overview
Table 86. Chiesi Respiratory Drug Product
Table 87. Chiesi Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Chiesi Sales Proportion of Respiratory Drug by Product in 2024
Table 89. Chiesi Sales Proportion of Respiratory Drug by Application in 2024
Table 90. Chiesi Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 91. Chiesi Recent Developments
Table 92. Mylan Company Information
Table 93. Mylan Description and Business Overview
Table 94. Mylan Respiratory Drug Product
Table 95. Mylan Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Mylan Sales Proportion of Respiratory Drug by Product in 2024
Table 97. Mylan Sales Proportion of Respiratory Drug by Application in 2024
Table 98. Mylan Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 99. Mylan Recent Developments
Table 100. Sumitomo Dainippon Company Information
Table 101. Sumitomo Dainippon Description and Business Overview
Table 102. Sumitomo Dainippon Respiratory Drug Product
Table 103. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Sumitomo Dainippon Sales Proportion of Respiratory Drug by Product in 2024
Table 105. Sumitomo Dainippon Sales Proportion of Respiratory Drug by Application in 2024
Table 106. Sumitomo Dainippon Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 107. Sumitomo Dainippon Recent Developments
Table 108. Merck Company Information
Table 109. Merck Description and Business Overview
Table 110. Merck Respiratory Drug Product
Table 111. Merck Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Merck Sales Proportion of Respiratory Drug by Product in 2024
Table 113. Merck Sales Proportion of Respiratory Drug by Application in 2024
Table 114. Merck Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 115. Merck Recent Developments
Table 116. Beximco Company Information
Table 117. Beximco Description and Business Overview
Table 118. Beximco Respiratory Drug Product
Table 119. Beximco Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Beximco Sales Proportion of Respiratory Drug by Product in 2024
Table 121. Beximco Sales Proportion of Respiratory Drug by Application in 2024
Table 122. Beximco Sales Proportion of Respiratory Drug by Geographic Area in 2024
Table 123. Beximco Recent Developments
Table 124. North America Respiratory Drug Sales by Country (2020-2025) & (M Units)
Table 125. North America Respiratory Drug Sales by Country (2026-2031) & (M Units)
Table 126. North America Respiratory Drug Revenue by Country (2020-2025) & (US$ Million)
Table 127. North America Respiratory Drug Revenue by Country (2026-2031) & (US$ Million)
Table 128. North America Respiratory Drug Sales by Type (2020-2025) & (M Units)
Table 129. North America Respiratory Drug Sales by Application (2020-2025) & (M Units)
Table 130. Asia-Pacific Respiratory Drug Sales by Region (2020-2025) & (M Units)
Table 131. Asia-Pacific Respiratory Drug Sales by Region (2026-2031) & (M Units)
Table 132. Asia-Pacific Respiratory Drug Revenue by Region (2020-2025) & (US$ Million)
Table 133. Asia-Pacific Respiratory Drug Revenue by Region (2026-2031) & (US$ Million)
Table 134. Asia-Pacific Respiratory Drug Sales by Type (2020-2025) & (M Units)
Table 135. Asia-Pacific Respiratory Drug Sales by Application (2020-2025) & (M Units)
Table 136. Europe Respiratory Drug Sales by Country (2020-2025) & (M Units)
Table 137. Europe Respiratory Drug Sales by Country (2026-2031) & (M Units)
Table 138. Europe Respiratory Drug Revenue by Country (2020-2025) & (US$ Million)
Table 139. Europe Respiratory Drug Revenue by Country (2026-2031) & (US$ Million)
Table 140. Europe Respiratory Drug Sales by Type (2020-2025) & (M Units)
Table 141. Europe Respiratory Drug Sales by Application (2020-2025) & (M Units)
Table 142. Latin America Respiratory Drug Sales by Country (2020-2025) & (M Units)
Table 143. Latin America Respiratory Drug Sales by Country (2026-2031) & (M Units)
Table 144. Latin America Respiratory Drug Revenue by Country (2020-2025) & (US$ Million)
Table 145. Latin America Respiratory Drug Revenue by Country (2026-2031) & (US$ Million)
Table 146. Latin America Respiratory Drug Sales by Type (2020-2025) & (M Units)
Table 147. Latin America Respiratory Drug Sales by Application (2020-2025) & (M Units)
Table 148. Middle East and Africa Respiratory Drug Sales by Country (2020-2025) & (M Units)
Table 149. Middle East and Africa Respiratory Drug Sales by Country (2026-2031) & (M Units)
Table 150. Middle East and Africa Respiratory Drug Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Respiratory Drug Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Respiratory Drug Sales by Type (2020-2025) & (M Units)
Table 153. Middle East and Africa Respiratory Drug Sales by Application (2020-2025) & (M Units)
Table 154. Respiratory Drug Key Raw Materials, Industry Status and Trend
Table 155. Respiratory Drug Key Raw Materials and Upstream Suppliers
Table 156. Respiratory Drug Clients Status and Trend
Table 157. Respiratory Drug Typical Clients
Table 158. Respiratory Drug Distributors
Table 159. Respiratory Drug Market Trends
Table 160. Respiratory Drug Market Drivers
Table 161. Respiratory Drug Market Challenges
Table 162. Respiratory Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Respiratory Drug Product Picture
Figure 2. Global Respiratory Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Respiratory Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Inhalable & Nasal Spray Product Picture
Figure 5. Oral Product Picture
Figure 6. Others Product Picture
Figure 7. Global Respiratory Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Respiratory Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Hospital
Figure 10. Drugs Store
Figure 11. Respiratory Drug Report Years Considered
Figure 12. Global Respiratory Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Respiratory Drug Market Size 2020-2031 (US$ Million)
Figure 14. Global Respiratory Drug Sales 2020-2031 (M Units)
Figure 15. Global Respiratory Drug Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Respiratory Drug Revenue Market Share by Region (2020-2031)
Figure 17. Global Respiratory Drug Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Respiratory Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Respiratory Drug Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 20. Global Respiratory Drug Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Respiratory Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Respiratory Drug Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 23. Inhalable & Nasal Spray of Respiratory Drug Revenue Market Share by Application, 2024 VS 2031
Figure 24. Oral of Respiratory Drug Revenue Market Share by Application, 2024 VS 2031
Figure 25. Others of Respiratory Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Respiratory Drug Sales Share by Manufacturer in 2024
Figure 27. Respiratory Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Inhalable & Nasal Spray Market Sales Proportion by Manufacturer in 2024
Figure 29. Oral Market Sales Proportion by Manufacturer in 2024
Figure 30. Others Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Respiratory Drug Revenue 2020-2031 (US$ Million)
Figure 32. North America Respiratory Drug Sales Market Share by Type (2020-2025)
Figure 33. North America Respiratory Drug Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Respiratory Drug Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Respiratory Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Respiratory Drug Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Respiratory Drug Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Respiratory Drug Sales Market Share by Application (2020-2025)
Figure 39. Europe Respiratory Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Respiratory Drug Sales Market Share by Country (2020-2031)
Figure 41. Europe Respiratory Drug Revenue Market Share by Country (2020-2031)
Figure 42. Europe Respiratory Drug Sales Market Share by Type (2020-2025)
Figure 43. Europe Respiratory Drug Sales Market Share by Application (2020-2025)
Figure 44. Latin America Respiratory Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Respiratory Drug Sales Market Share by Country (2020-2031)
Figure 46. Latin America Respiratory Drug Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Respiratory Drug Sales Market Share by Type (2020-2025)
Figure 48. Latin America Respiratory Drug Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Respiratory Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Respiratory Drug Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Respiratory Drug Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Respiratory Drug Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Respiratory Drug Sales Market Share by Application (2020-2025)
Figure 54. Respiratory Drug Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Respiratory Drug Raw Materials by Region in 2024
Figure 56. Respiratory Drug Distribution Channels
Figure 57. Global Respiratory Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Respiratory Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
